ACSL4 and hepatocellular carcinoma: In chronic injury-dependent hepatocellular carcinoma (HCC), ACSL4 deficiency alleviates hepatocyte death and proliferation, thereby suppressing HCC development by mitigating liver injury and fibrosis (31).